Raymond James analyst Andrew Cooper downgrades Veracyte (NASDAQ:VCYT) from Outperform to Market Perform.
Morgan Stanley Maintains Overweight on Marathon Petroleum, Raises Price Target to $120
Morgan Stanley analyst Connor Lynagh maintains Marathon Petroleum (NYSE:MPC) with a Overweight and raises the price target from $115 to $120.